 Patricia Yoon
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 6 | 2023 | 221 | 1.390 |
Why?
| | Cochlear Implantation | 3 | 2022 | 76 | 1.100 |
Why?
| | Cochlear Implants | 3 | 2022 | 91 | 1.090 |
Why?
| | Otitis Media | 6 | 2023 | 165 | 0.880 |
Why?
| | Deafness | 1 | 2020 | 77 | 0.610 |
Why?
| | Hearing Loss, Sensorineural | 3 | 2021 | 67 | 0.500 |
Why?
| | Hearing Loss, Central | 2 | 2023 | 6 | 0.390 |
Why?
| | Velopharyngeal Insufficiency | 2 | 2012 | 11 | 0.360 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.330 |
Why?
| | Social Perception | 1 | 2011 | 108 | 0.330 |
Why?
| | Professional-Patient Relations | 1 | 2011 | 145 | 0.330 |
Why?
| | Psychotherapy | 1 | 2011 | 167 | 0.320 |
Why?
| | Down Syndrome | 3 | 2023 | 496 | 0.320 |
Why?
| | Microbiota | 5 | 2023 | 762 | 0.290 |
Why?
| | Vocal Cord Paralysis | 1 | 2007 | 28 | 0.280 |
Why?
| | Ear, Middle | 5 | 2023 | 85 | 0.210 |
Why?
| | Audiometry | 2 | 2020 | 29 | 0.200 |
Why?
| | Hearing Tests | 1 | 2003 | 47 | 0.190 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 2 | 2023 | 50 | 0.190 |
Why?
| | Child | 12 | 2023 | 21935 | 0.190 |
Why?
| | Cardiac Surgical Procedures | 1 | 2007 | 530 | 0.190 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2021 | 36 | 0.180 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 14 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 42 | 0.180 |
Why?
| | Nasopharynx | 1 | 2022 | 76 | 0.180 |
Why?
| | Lymphatic System | 1 | 2001 | 13 | 0.180 |
Why?
| | Jugular Veins | 1 | 2001 | 41 | 0.180 |
Why?
| | Aneurysm | 1 | 2001 | 31 | 0.180 |
Why?
| | Plasminogen | 1 | 2020 | 30 | 0.170 |
Why?
| | Hydrocephalus | 1 | 2021 | 106 | 0.170 |
Why?
| | Palate, Soft | 2 | 2012 | 15 | 0.160 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2003 | 257 | 0.160 |
Why?
| | Pharynx | 2 | 2012 | 59 | 0.160 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.150 |
Why?
| | Infant | 10 | 2023 | 9465 | 0.150 |
Why?
| | Middle Ear Ventilation | 1 | 2018 | 15 | 0.150 |
Why?
| | Deoxyribonuclease I | 1 | 2018 | 39 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 341 | 0.150 |
Why?
| | Equipment Failure | 1 | 2018 | 108 | 0.140 |
Why?
| | Hearing Loss, Bilateral | 1 | 2017 | 12 | 0.140 |
Why?
| | Hearing Loss, Conductive | 1 | 2017 | 25 | 0.140 |
Why?
| | Down-Regulation | 1 | 2019 | 657 | 0.130 |
Why?
| | Child, Preschool | 8 | 2023 | 11074 | 0.130 |
Why?
| | Humans | 24 | 2023 | 137585 | 0.130 |
Why?
| | Hearing Aids | 1 | 2017 | 77 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 812 | 0.120 |
Why?
| | Treatment Outcome | 6 | 2021 | 10811 | 0.120 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 549 | 0.120 |
Why?
| | Postoperative Complications | 3 | 2022 | 2654 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1164 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 514 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 991 | 0.100 |
Why?
| | Male | 15 | 2023 | 67762 | 0.100 |
Why?
| | Female | 15 | 2023 | 73304 | 0.100 |
Why?
| | Leukemia, Megakaryoblastic, Acute | 1 | 2012 | 10 | 0.100 |
Why?
| | Infant, Newborn | 4 | 2023 | 6079 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1774 | 0.090 |
Why?
| | Mutation | 2 | 2021 | 3958 | 0.090 |
Why?
| | Neonatal Screening | 2 | 2023 | 169 | 0.090 |
Why?
| | Acoustic Impedance Tests | 2 | 2017 | 13 | 0.090 |
Why?
| | Prosthesis Design | 1 | 2011 | 327 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 591 | 0.070 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2007 | 52 | 0.070 |
Why?
| | Nasal Cavity | 1 | 2006 | 52 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2023 | 15657 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2020 | 3284 | 0.060 |
Why?
| | Observer Variation | 1 | 2006 | 343 | 0.060 |
Why?
| | Oval Window, Ear | 1 | 2004 | 1 | 0.060 |
Why?
| | Otosclerosis | 1 | 2004 | 5 | 0.060 |
Why?
| | Stapes Surgery | 1 | 2004 | 10 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2018 | 5131 | 0.060 |
Why?
| | Auditory Threshold | 1 | 2004 | 41 | 0.050 |
Why?
| | Adolescent | 5 | 2023 | 21513 | 0.050 |
Why?
| | Endoscopy | 1 | 2006 | 318 | 0.050 |
Why?
| | Nasal Septum | 1 | 2003 | 25 | 0.050 |
Why?
| | Otoacoustic Emissions, Spontaneous | 1 | 2023 | 5 | 0.050 |
Why?
| | Audiometry, Evoked Response | 1 | 2003 | 12 | 0.050 |
Why?
| | Mice | 4 | 2022 | 17787 | 0.050 |
Why?
| | Rhinoplasty | 1 | 2003 | 29 | 0.050 |
Why?
| | Laser Therapy | 1 | 2004 | 130 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2003 | 216 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2426 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 63 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2001 | 62 | 0.040 |
Why?
| | Animals | 5 | 2022 | 36940 | 0.040 |
Why?
| | Neck | 1 | 2001 | 101 | 0.040 |
Why?
| | Young Adult | 2 | 2019 | 13209 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 51 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 76 | 0.040 |
Why?
| | Finland | 1 | 2019 | 85 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5757 | 0.040 |
Why?
| | Quality of Life | 1 | 2011 | 2892 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 242 | 0.040 |
Why?
| | Prospective Studies | 2 | 2018 | 7604 | 0.040 |
Why?
| | Chinchilla | 1 | 2018 | 34 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 188 | 0.040 |
Why?
| | Administration, Topical | 1 | 2018 | 151 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2018 | 282 | 0.030 |
Why?
| | Exome | 1 | 2018 | 231 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 452 | 0.030 |
Why?
| | Evoked Potentials, Auditory | 1 | 2017 | 180 | 0.030 |
Why?
| | Adult | 4 | 2019 | 37929 | 0.030 |
Why?
| | Middle Aged | 3 | 2019 | 33479 | 0.030 |
Why?
| | Databases, Factual | 1 | 2022 | 1357 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 730 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1353 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 795 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 971 | 0.030 |
Why?
| | Mass Screening | 1 | 2022 | 1287 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2847 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2189 | 0.020 |
Why?
| | Mastoid | 1 | 2012 | 13 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1622 | 0.020 |
Why?
| | Time Factors | 1 | 2003 | 6828 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2804 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2734 | 0.020 |
Why?
| | Movement | 1 | 2012 | 278 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2607 | 0.020 |
Why?
| | Risk Factors | 1 | 2003 | 10388 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4565 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 5079 | 0.020 |
Why?
| | Audiometry, Pure-Tone | 1 | 2004 | 30 | 0.010 |
Why?
| | Bone Conduction | 1 | 2004 | 23 | 0.010 |
Why?
| | Cartilage | 1 | 2003 | 188 | 0.010 |
Why?
| | United States | 1 | 2019 | 14841 | 0.010 |
Why?
| | Reoperation | 1 | 2003 | 573 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2004 | 3556 | 0.010 |
Why?
| | Aged | 1 | 2004 | 23961 | 0.000 |
Why?
|
|
Yoon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|